MyFinsight
Home
Blog
About
Proceeds from private
offerings
$319,492
(-82.90%↓ Y/Y)
Due to related
parties, net
$255,858
(675.36%↑ Y/Y)
Net cash provided by
financing activities
$226,209
(-90.40%↓ Y/Y)
Effect of exchange rate
changes on cash and cash...
$11,355
(125.93%↑ Y/Y)
Canceled cashflow
$349,141
Net decrease in cash
and cash...
-$108,380
(-151.00%↓ Y/Y)
Canceled cashflow
$237,564
Stock-based compensation
$253,041
(-84.38%↓ Y/Y)
Due from related
parties
-$109,771
(-157.65%↓ Y/Y)
Prepaid expenses and
other current assets
-$107,622
(-245.86%↓ Y/Y)
Amortization of right-of-use
asset
$82,979
(-54.17%↓ Y/Y)
Accrued expenses and
other current...
$45,663
(96.42%↑ Y/Y)
Loss on investment in
equity securities
-$24,766
(74.15%↑ Y/Y)
Tenant security
deposit
$22,090
(-10.60%↓ Y/Y)
Depreciation
$6,516
(-52.50%↓ Y/Y)
Loss on short-term
investment
-$36
Repayment from related
parties
-$34,444
(-124.18%↓ Y/Y)
something is missing
$32,000
Payment for long-term
investment
-$11,597
something is missing
-$319,492
Repayment of short-term
loans
$29,649
(-49.64%↓ Y/Y)
Net cash used in
operating activities
-$244,413
(82.96%↑ Y/Y)
Canceled cashflow
$652,484
Net cash used in
investing activities
-$101,531
(84.75%↑ Y/Y)
Canceled cashflow
$78,041
Net loss
-$810,481
(75.27%↑ Y/Y)
Operating lease
liabilities
-$79,605
(56.03%↑ Y/Y)
Taxes payables
-$5,945
(-125.28%↓ Y/Y)
Other non-cash
expenses
$866
(-99.73%↓ Y/Y)
Loan to related
parties
$147,572
(-81.74%↓ Y/Y)
Payment for convertible
notes receivable-...
$32,000
Back
Back
Cash Flow
ABVC BIOPHARMA, INC. (ABVC)
ABVC BIOPHARMA, INC. (ABVC)
source: myfinsight.com